POLYCLONAL Y-90 LABELED ANTIFERRITIN FOR REFRACTORY HODGKINS-DISEASE

被引：45
|
作者：
VRIESENDORP, HM
HERPST, JM
LEICHNER, PK
KLEIN, JL
ORDER, SE
机构：
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1989年 / 17卷 / 04期
关键词：
D O I：
10.1016/0360-3016(89)90072-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：815 / 821
页数：7
相关论文
共 50 条
  • [31] Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody
    Decaudin, Didier
    Levy, Raphaeel
    Lokiec, Francois
    Morschhauser, Franck
    Djeridane, Malika
    Kadouche, Jean
    Pecking, Alain
    ANTI-CANCER DRUGS, 2007, 18 (06) : 725 - 731
  • [32] Radioimmunotherapy (RIT) of refractory or relapsed Hodgkin's lymphoma with 90Yttrium-labeled antiferritin antibody.
    Decaudin, D.
    Kadouche, J.
    Levy, R.
    Belhamiche, M.
    Arnaud, P.
    Alberini, J. L.
    Lokiec, F. M.
    Pecking, A. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 108S - 108S
  • [33] A Phase 2 Open-Label Safety and Tolerability Study of Single Intravenous (IV) Escalating Doses of 90Yttrium-Labeled Antiferritin Antibodies (90Y-Antiferritin) in Patients with Relapsed or Refractory Hodgkin Lymphoma
    Decaudin, Didier
    Pecking, Alain
    Lokiec, Francois
    Kadouche, Jean
    Allard, Stephane E.
    BLOOD, 2014, 124 (21)
  • [34] COMBINATION CHEMOTHERAPY WITH DOXORUBICIN AND LOMUSTINE - TREATMENT OF REFRACTORY HODGKINS-DISEASE
    WILLIAMS, SD
    EINHORN, LH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 238 (15): : 1659 - 1661
  • [35] Ibritumomab tiuxetan Y-90/rituximabFatal interstitial lung disease (first report for ibritumomab tiuxetan Y-90): case report
    Reactions Weekly, 2012, 1395 (1) : 24 - 24
  • [36] Lung shunting in therapy with Y-90 labeled glass microspheres for liver cancer
    Ruano, R.
    Barquero Sanz, M.
    Rodriguez, D.
    Gamazo, C.
    de la LLana, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S584 - S585
  • [37] Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with Y-90 microspheres
    Yim, Sun Young
    Kim, Jin Dong
    Jung, Jin Yong
    Kim, Chang Ha
    Seo, Yeon Seok
    Yim, Hyung Joon
    Um, Soon Ho
    Ryu, Ho Sang
    Kim, Yun Hwan
    Kim, Chong Suk
    Shin, Eun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (03) : 300 - 305
  • [38] DEXA-BEAM IN PATIENTS WITH HODGKINS-DISEASE REFRACTORY TO MULTIDRUG CHEMOTHERAPY REGIMENS - A TRIAL OF THE GERMAN HODGKINS-DISEASE STUDY-GROUP
    PFREUNDSCHUH, MG
    RUEFFER, U
    LATHAN, B
    SCHMITZ, N
    BROSTEANU, O
    HASENCLEVER, D
    HAAS, R
    KIRCHNER, H
    KOCH, P
    KUSE, R
    LOEFFLER, M
    DIEHL, V
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) : 580 - 586
  • [39] Y-90 Zevalin (anti-CD20) Radioimmunotherapy for adults with relapsed/refractory Hodgkin's disease
    Lastoria, S.
    Aloj, L.
    Caraco, C.
    Tommaselli, A.
    Frigeri, F.
    Pinto, A.
    De Martinis, F.
    Casale, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S240 - S240
  • [40] MINI-BEAM AS SALVAGE CHEMOTHERAPY FOR REFRACTORY HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA
    STEWART, AK
    BRANDWEIN, JM
    SUTCLIFFE, SB
    SCOTT, JG
    KEATING, A
    LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 111 - 115
12345